Myriad Genetics Inc (MYGN)

Debt-to-capital ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	701,100	783,200	885,800	967,800	881,000
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $701,100K)
= 0.00

The debt-to-capital ratio for Myriad Genetics Inc for the years December 31, 2020 through December 31, 2024, remained consistently at 0.00. This implies that the company has not used any debt financing to fund its operations, and its capital structure is solely reliant on equity. A debt-to-capital ratio of 0.00 indicates a low financial risk as it suggests that the company is not burdened by debt obligations relative to its total capital. This could be advantageous for Myriad Genetics Inc as it may have lower interest expenses and potentially better access to capital in the future. However, it's important to note that a very low debt-to-capital ratio could also signal underutilization of debt for potential leverage or growth opportunities. Investors and stakeholders should further assess the company's overall financial health and growth strategies in light of this consistent ratio.